Camber Capital Surges Stake In Sequenom Inc. (SQNM) To Over 5%
Camber Capital Management, managed by Stephen Dubois, is bullish on Sequenom Inc. (NASDAQ:SQNM).
Hedge Fund - Camber Capital Management
News, Interviews, and Investor Letters
- First
- << Previous
- 21 - 27
Camber Capital Management Reveals New Position in Cardica, Inc. (CRDC)
Stephen Dubois' Camber Capital Management revealed a new stake in Cardica, Inc. (NASDAQ:CRDC).
Hedge Fund News: John Paulson, Ray Dalio & Paul Singer
The European unit of US hedge fund firm Paulson & Co, which is run by billionaire investor John Paulson, posted improved profits in the year to the end of March, marking a recovery from a drop in performance...
Camber Capital Raises Exposure to CONMED Corporation (CNMD)
Stephen DuBois' Camber Capital has raised its holding in CONMED Corporation (NASDAQ:CNMD).
Stephen DuBois's Hedge Fund Now Owns a Large Position in Ariad Pharmaceuticals
Stephen DuBois, Ariad Pharmaceuticals: In a new filing just reported to the SEC, Stephen DuBois's Camber Capital disclosed a new 5.4% stake in Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA).
Camber Capital Takes Big Position in Med-Tech Company Biolase
Camber Capital Management, a hedge fund managed by Stephen Dubois recently disclosed adding a new position to its equity portfolio, BIOLASE Inc (NASDAQ:BIOL).
Hedge Funds Are Selling Humana Inc (HUM)
In the financial world, there are many metrics shareholders can use to analyze publicly traded companies. A couple of the most innovative are hedge fund and insider trading movement.
- First
- << Previous
- 21 - 27